(Last updated : 2024-10-17 15:26:01)
  IIDZUKA Yuki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Internal Medicine, Division of Hematology
   Position  
■ Published papers
1. Original article  Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. 2024/02/27
2. Original article  Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients. 2022/02
3. Case report  Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports. 2021/09
4. Original article  Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. 2020/04
5. Original article  Herpes zoster after autologous haematopoietic stem cell transplantation without antiviral prophylaxis. 2019/09
Display all(7)
■ Academic conference presentation
1. Clinical course of immune thrombocytopenia after COVID-19 vaccination  2022/10/16
2. Clinical features of MTX-associated lymphoproliferative disorders in rheumatoid arthritis patients  2022/10/16
3. 4 cases of COVID-19 infection in patients with hematological diseases  2021/09/23
4. A case of primary mediastinal large B-cell lymphoma with pancreas involvement  2021/09/23
5. Retrospective analysis of chronic myelomonocytic leukemia  2021/09/23
Display all(21)
■ Education
1. 2004/04~2010/03 Faculty of Medicine, Tokyo Women's Medical University, Graduated